{"name":"Helsinn Therapeutics (U.S.), Inc","slug":"helsinn-therapeutics-u-s-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Valchlor","genericName":"Valchlor","slug":"valchlor","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Valchlor","genericName":"Valchlor","slug":"valchlor","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPbi04eXJOX3dZU0tQVVBBNEVMNUFUQTVid29IR0hYdTZXOVRTNGIwZTZFaE9Ha2dHVHc4RWhTYjAwei1QV1d4R1RuYVpuLUZKeXVHZ3k5VVNZOXpXSGo3YzVBZTBqWDRNUkpUQ2RXUHo2ZVZaRVV5bExKdm5MaGEtc3BIU3JMNjAyOGkxYjNhMFVXaXBPVnIwcDVSTTY3ejdsODg0WjlvOF9oaE5yN0pCdUVMWWJLcFF6ZFp4TElCSjcwNlVmaXdjQnlYTGY4UUhNZjRMazg0T1BCNDYxb2JWQmRBcFYtcmRFSkJPZlhEQk1WS1FHQ045MFJjUWhCblp6QTZwcjcwRVhKTDVacDFDYkx6SFQ0R055bkRDa3lBU2c0MWpHX2VkdGpiNzNway16Ymkwb1Qwc0F2WEU?oc=5","date":"2025-01-28","type":"pipeline","source":"globenewswire.com","summary":"Knight Therapeutics and Helsinn Healthcare SA Expand - globenewswire.com","headline":"Knight Therapeutics and Helsinn Healthcare SA Expand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTDM1LTVDNzB0YU1xUldodURyUjQ3a0Qxc0pXWTJ1M1RZdFBRSW9SN1AxZlJsWEZoSXFzTGREZ3VvR3ZZTUNBdi1RX3pXZlJLZkNQb3ViaXhCb19xZElhRzJJcjhDbTB0OEZzaWlSMHdFd0dON3NXdHJIT3JTTWFiajNJN2RDQWJVcWI3S25Jb0xBQ2c0eDl4OThMVWRIR1RoNmswNEZXTjREUGJfaGJIV1hpdmFJUVVFZ3ZB?oc=5","date":"2023-05-29","type":"regulatory","source":"Citeline News & Insights","summary":"Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else - Citeline News & Insights","headline":"Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else - Citeline News & Insights","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNWjZSZVRDRFJoeHdfNmEycG9QSXZxeGpULUtKMzVIQ2xQX0pLVHJlZlNZUFhiVmR3QUlXalFPeWo2R3B4TFA2RlMwMGxnVjR2Tm1zRGwtY2oyYzdYX2R5QS1MSjdsQ3VDSXM4M25Ud0pCNzIxb3JsWUlDbW9jb181N19JY2pyV1EyakZUQTJyck1ONWhUYldjSUc4NzNmbTJrTkRpZURmZjlIZ2tBRDA4TnFkUEtGVVJUbU5yeEJVakFYd3UyWjA1QzNn?oc=5","date":"2022-12-01","type":"pipeline","source":"OncLive","summary":"Helsinn Birex Pharmaceuticals Withdraws European MAA for Infigratinib for Advanced Cholangiocarcinoma - OncLive","headline":"Helsinn Birex Pharmaceuticals Withdraws European MAA for Infigratinib for Advanced Cholangiocarcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQYmg3X3BEVWlFeDFmUlJzejhTTTBNcVpJM1lCeGcwNkY5amZjUm12anF3cEpuVTdoNEZoNW1rREFFTjZlU3JlMENnUS1pU21nYXZTRXlqTlQ1VExWSDllTUZWdXNmcnYwTUtoM1F1TldIWWhvci1qV2t5eXRuU1FCNjlJRkZ5WjQzS09fUkcxUQ?oc=5","date":"2022-05-26","type":"pipeline","source":"Contract Pharma","summary":"Helsinn Establishes New R&D Hub in the U.S. - Contract Pharma","headline":"Helsinn Establishes New R&D Hub in the U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQcnlYVFVrNjNXU09oWGg3ZXZBcU13NENmYzVnNnZtTmwzdlNkRkd3Qlk2cUZBcl9ST0t2YnNYcm52QWZiYzRHcUFldGt0Y1ZoX1llSXFtRm5SQXMxNi1XeG5GZVFpazc5eG1Kd3ZsQzd1djRlOXVXUlFyQzFoWXhKVkpPOWJmRGRYVERnbTR5MXhQb00?oc=5","date":"2022-03-03","type":"pipeline","source":"finance.yahoo.com","summary":"Helsinn, BridgeBio Pharma Amend Infigratinib Pact For Oncology Indications - finance.yahoo.com","headline":"Helsinn, BridgeBio Pharma Amend Infigratinib Pact For Oncology Indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNS1dzanY4VGE5MFNmS3pKbVMybGJFLTZVdjU0OWIyTlNYRUVnejhlalFndkNGdWtYcEp2enQ5Z0V4NFRxZ3o0bGotX3lxZjBiczBSOEdjZXVWYWJjVzMtaVJUczFhX0pEVnJpaTNwVkJYNVhPUlhnVXF2NFdLLVRJQjBtUUpEWDJERldIanpjN0U4eTBjdjd2QmZ3d3l3M2R5RmVMZ1l4clBmcEVrcGVSM0Z5RG84RVliRmNhVFdSREdGVnd3UzMwQnpqdWY?oc=5","date":"2022-02-10","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Volunteer Voices: Allison Vavala, Helsinn, Chair of the DCAT Education Committee - DCAT Value Chain Insights","headline":"Volunteer Voices: Allison Vavala, Helsinn, Chair of the DCAT Education Committee","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPWUhnazA0aVBLUWlocWR0b3FBMXV2SVRIeXUzeHBPMHF5TzhDSTJ0d19HY0ZXQlRGd2ZlV0pKbXZjT0U2TDlSSktiRk04SWRFdU5ENms3V0ZkbU03cV9wenBzdDN3MEN2SFV2c21hQnAxZ3hUbDBqcklxZnFuZk50M05SaU9hMWxkNWtmZWNpMUZ3alV5VWtlZlQyTndjZw?oc=5","date":"2021-06-01","type":"regulatory","source":"BioSpace","summary":"FDA Approves BridgeBio-QED Therapeutics’ Targeted Liver Cancer Treatment Truseltiq - BioSpace","headline":"FDA Approves BridgeBio-QED Therapeutics’ Targeted Liver Cancer Treatment Truseltiq","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOXzdWN2lhMGNoVEtoZHBmVjFRZnZjMldxZWs1cEIyeXlxVFhxY0lEUmR5RXFydmFJQlYwaC03OU9Ia25DdHMtUXRkaG1yazByOUhVb2tES0N0MTBsWmtqVUNwRkN1QTlCMW5kMTRkdFY2Ym9VeVR1RC1PaDdBZUNjZE15THlFUQ?oc=5","date":"2019-12-06","type":"pipeline","source":"Nixon Peabody","summary":"SCOTUS Helsinn decision - Intellectual Property Alert - Nixon Peabody","headline":"SCOTUS Helsinn decision - Intellectual Property Alert","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNVDBQVjR4bG5JbElrU09QTWxDdUxnUkFrTUttZzN1WXhOamdwVmwxZGVJUEkwSUowUnVaMmo4Y0FXQXM2TnBJZ2l1WlZsbktWZmpHQ0J3amFIbzN0QXc1S2FlNFZxbmFKc0FucE1wUjNDaXlqV2syX3AyQkNqYXJmTw?oc=5","date":"2019-01-22","type":"pipeline","source":"IPWatchdog.com","summary":"Supreme Court decides Helsinn v. Teva, Secret Sale Qualifies as Prior Art Under the AIA - IPWatchdog.com","headline":"Supreme Court decides Helsinn v. Teva, Secret Sale Qualifies as Prior Art Under the AIA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQOEl0V1EtaFExSDJYSGhZV2dUZFV1amJ6OUcxQnJJZE95eTIxRElzX3EzQkhaUVVkMHBOUXZKYmNGLUxUenNWdWxaM1B0N2ZXd184Y01HSUZEWWpZUlZQLXRqZUZyN0VVdXBfYmk0Y2ZxSmlVcTY4WDYyQ182MjZNS1dENjdNNWRGTW9ST0lmM3ViaE1mMHM0UTRB?oc=5","date":"2019-01-22","type":"pipeline","source":"Jones Day","summary":"Secret Sales Are Still Prior Art: U.S. Supreme Court Affirms Helsinn Healthcare - Jones Day","headline":"Secret Sales Are Still Prior Art: U.S. Supreme Court Affirms Helsinn Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPNi1aQ0NMMWJjTm1CYTk4SV90OEdVUjBNNDZDc3NEYmdjRWlDS0cyUzVPblEwVGNHRVNEalpnTTl2QlVDZWFEUzFWQ3VrS1J2cUtFRkUxc0hfWExNVjNDLUY3Mk13VjRoWUNtOVU5aW5GdkhNOFdpNFNIU1hjNjAwM3Azb2daenRJTXZkTXBDN3c0NVVJQ2Z1LTViLUxfTHM?oc=5","date":"2018-03-21","type":"deal","source":"The Pharma Letter","summary":"Helsinn to acquire worldwide rights to Valchlor/Ledaga - The Pharma Letter","headline":"Helsinn to acquire worldwide rights to Valchlor/Ledaga","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQZEZaeWZlNG4zajkxaEZCVmxIY3hNOUowNGNQdGstYVdTRVhWZGlnQmJsNWtadG1EVDhPc0lrRmhiWjFCS2JPbWNIaGFZWld5QkZtQkRvYzdUdFUxVVhld293Szd1b1ptRGpCOUYtUFZBbmRNSUZCRkx1U1BJN2R4el9ETUJYNFhZcTVpVHl2aVN0N2dDeVh5T0FseVk1Z0t4Y2pHNkNoVUVmc21EeGhmcksxaWw0RFpFbUwtdWxXbzROZVpubDd2cjdFelVoUExuOWU2dFlLaHhMSjlCYU5tTjV0cExDa1hBRlV3Z1hZMndQSWREZUJZV2tJNVkxSC1JeTBBMEZybUpfUGt0bEtydzF4RE5QeThjWDhpVjF3dGVFWmRCMGhkQ3I3QVlOOVVaSElTX2hxbw?oc=5","date":"2017-03-21","type":"pipeline","source":"PR Newswire","summary":"Available Now: New Toolkit Encourages Better Communication to Help Prevent Patients from Suffering in Silence Due to Chemotherapy-induced Nausea and Vomiting - PR Newswire","headline":"Available Now: New Toolkit Encourages Better Communication to Help Prevent Patients from Suffering in Silence Due to Che","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}